![]() Omeros Omeros Corporation is a biopharmaceutical company developing products focused on inflammation and central nervous system disorders as well as immune-related diseases, including cancers. | ![]() Otonomy Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear. | ![]() Leap Therapeutics Leap Therapeutics (also known as Cypherpunk Technologies, formerly known as HealthCare Pharmaceuticals) is a biopharmaceutical company developing targeted and immuno-oncology therapeutics. | |
Founding Date | Founding Date 1994 | Founding Date 2008 | Founding Date 2011 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Seattle, US HQ | Locations San Diego, US HQ | Locations Cambridge, US HQ |
Employees | Employees 1968% decrease | Employees 49 | Employees 688% decrease |
Valuation ($) | Valuation ($) 248.6 m | Valuation ($) 5.3 m | Valuation ($) 176.4 m |
Financial | |||
Net income | Net income ($3.4m) (FY, 2025) | Net income ($51.2m) (FY, 2021) | Net income $4.8m (FY, 2025) |
Operating ⚠ | |||
Phase I Trials Products | Phase I Trials Products 3 (FY, 2021) | Phase I Trials Products 1 (FY, 2016) | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products 2 (FY, 2021) | Phase II Trials Products 2 (FY, 2016) | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products 2 (FY, 2021) | Phase III Trials Products 2 (FY, 2016) | Phase III Trials Products N/A |
Funding | |||
Total funding raised | Total funding raised $ 354.8m | Total funding raised $ 153.4m | Total funding raised N/A |

Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
View company
Leap Therapeutics (also known as Cypherpunk Technologies, formerly known as HealthCare Pharmaceuticals) is a biopharmaceutical company developing targeted and immuno-oncology therapeutics.
View company